Aquatic Capital Management LLC Sells 9,308 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Aquatic Capital Management LLC cut its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 74.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,192 shares of the technology company's stock after selling 9,308 shares during the period. Aquatic Capital Management LLC's holdings in Simulations Plus were worth $89,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Proficio Capital Partners LLC acquired a new stake in Simulations Plus in the 4th quarter valued at about $719,000. Barclays PLC lifted its stake in Simulations Plus by 390.6% in the 3rd quarter. Barclays PLC now owns 28,473 shares of the technology company's stock worth $911,000 after acquiring an additional 22,669 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Simulations Plus by 106.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company's stock valued at $1,517,000 after purchasing an additional 24,371 shares during the period. Sei Investments Co. purchased a new stake in shares of Simulations Plus in the fourth quarter worth approximately $330,000. Finally, Tributary Capital Management LLC boosted its holdings in shares of Simulations Plus by 21.7% during the fourth quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company's stock worth $11,047,000 after purchasing an additional 70,526 shares during the period. Institutional investors own 78.08% of the company's stock.

Simulations Plus Price Performance

Shares of NASDAQ SLP traded down $0.23 during trading hours on Friday, reaching $30.02. The stock had a trading volume of 150,697 shares, compared to its average volume of 207,594. Simulations Plus, Inc. has a twelve month low of $23.01 and a twelve month high of $51.22. The company has a market cap of $603.73 million, a price-to-earnings ratio of 75.05 and a beta of 1.10. The business's fifty day moving average is $28.73 and its two-hundred day moving average is $30.29.

Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.06. The business had revenue of $22.43 million during the quarter, compared to analysts' expectations of $21.93 million. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm's revenue for the quarter was up 22.5% on a year-over-year basis. During the same quarter last year, the company posted $0.20 EPS. Sell-side analysts forecast that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several brokerages have weighed in on SLP. StockNews.com raised Simulations Plus from a "sell" rating to a "hold" rating in a research report on Monday, April 28th. KeyCorp lifted their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday, April 16th. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Simulations Plus currently has a consensus rating of "Moderate Buy" and a consensus target price of $50.00.

Insider Transactions at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the transaction, the director now directly owns 3,344,157 shares in the company, valued at approximately $112,062,701.07. This represents a 0.59 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 19.40% of the stock is owned by company insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.